Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: An important cause of stroke in young people

Postgraduate Medical Journal

Volumn 88, Issue 1040, 2012, Pages 326-334

  Goodfellow, John Aaron ^a   Dani, Krishna ^a   Stewart, Willie ^a   Santosh, Celestine ^a   McLean, John ^a   Mulhern, Sharon ^b   Razvi, Saif ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b Ayrshire Central Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DICHLOROACETIC ACID; IDEBENONE; MITOCHONDRIAL DNA; PYRUVATE DEHYDROGENASE; UBIDECARENONE;

ADULT; ARTICLE; ATROPHY; BASAL GANGLION; BRAIN CORTEX LESION; BRAIN ISCHEMIA; CASE REPORT; CELL DAMAGE; CELL TRANSPLANTATION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EDEMA; EXERCISE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEMIANOPIA; HEMIPARESIS; HUMAN; HYPERMETABOLISM; KETOGENIC DIET; LACTATE BLOOD LEVEL; LUMBAR PUNCTURE; MELAS SYNDROME; MERRF SYNDROME; MITOCHONDRION; MUSCLE BIOPSY; MYOCLONUS EPILEPSY; NAUSEA AND VOMITING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE PHOSPHORYLATION; PERCEPTION DEAFNESS; PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); SEIZURE; SHORT STATURE; STROKE; VASCULITIS; VASTUS LATERALIS MUSCLE;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; HUMANS; MELAS SYNDROME; MUTATION; STROKE; YOUNG ADULT;

EID: 84861185548     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2011-130326     Document Type: Article

References (44)

1. Pavlakis SG, Philips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481-8
2. Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes (MELAS): current concepts. J Child Neurol 1994;9:4-13
3. Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992;42:545-50
4. Ciafaloni E, Ricci E, Shanske S, et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992;31:391-8
5. Yatsuga S, Povalko N, Nishioka J, et al. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta. Published Online First: 1 April 2011. doi:10.1016/j.bbagen.2011.03.015
6. Kaufmann P, Engelstad K, Wei Y, et al. Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype. Neurology 2011;77:1965-71
7. Kim IO, Kim JH, Kim WS, et al. Mitochondrial myopathy-encephalopathy-lactic acidosis- and strokelike episodes (MELAS) syndrome: CT and MR findings in seven children. AJR Am J Roentgenol 1996;166:641-5
8. Sue CM, Crimmins DS, Soo YS, et al. Neuroradiological features of six kindreds with MELAS tRNA(Leu) A2342G point mutation: implications for pathogenesis. J Neurol Neurosurg Psych 1998;65:233-40
9. Sheerin F, Pretorius PM, Briley D, et al. Differential diagnosis of restricted diffusion confined to the cerebral cortex. Clin Radiol 2008;63:1245-53
10. Yoneda M, Maeda M, Kimura H, et al. Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology 1999;53:2182-4
11. Wang XY, Noguchi K, Takashima S, et al. Serial diffusion-weighted imaging in a patient with MELAS and presumed cytotoxic oedema. Neuroradiology 2003;45:640-3
12. Abe K, Inui T, Hirono N, et al. Fluctuating MR images with mitochondrial encephalopathy, lactic acidosis, stroke-like syndrome (MELAS). Neuroradiology 1990;32:77.
13. Kim JH, Lim MK, Jeon TY, et al. Diffusion and perfusion characteristics of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode) in thirteen patients. Korean J Radiol 2011;12:15-24
14. Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR Am J Neuroradiol 1995;16(2):233-9
15. Bianchi MC, Tosetti M, Battini R, et al. Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic significance. Am J Neuroradiol 2003:1958-66
16. Saneto RP, Friedman SD, Shaw DWW. Neuroimaging of mitochondrial disease. Mitochondrion 2008;8(5-6):396-413
17. Ikawa M, Okazawa H, Arakawa K, et al. PET imaging of redox and energy states in stroke-like episodes of MELAS. Mitochondrion 2009;9:144-8
18. Sarnat HB, Marin-Garcia J. Pathology of mitochondrial encephalomyopathies. Can J Neurol Sci 2005;32:152-66
19. Ma Y, Fang F, Yang Y, et al. The study of mitochondrial A3243G mutation in different samples. mitochondrion 2009;9:139-43. Mitochondrion 2008:8; 396-413.
20. Wong LJ, Scaglia F, Graham BH, et al. Current molecular diagnostic algorithm for mitochondrial disorders. Mol Genet Metab 2010;100:111-17
21. Goto Y, Nonaka I, Horai S. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encenphalomyopathies. Nature 1990;348:651-3
22. Sato W, Hayasaka K, Komatsu K, et al. Genetic analysis of three pedigrees of mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes (MELAS). Am J Hum Genet 1992;50:655-7
23. Majamaa K, Moilanen JS, Uimonen S, et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet 1998;63:447-54
24. Elliott HR, Samuels DC, Eden JA, et al. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008;83:254-60
25. Rahman S, Poulton J, Marchington D, et al. Decrease of 3243 A->G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. Am J Hum Genet 2001;68:238-40
26. Goto Y, Tsugane K, Tanabe Y, et al. A new point mutation at nucleotide pair 3291 of the mitochondrial tRNA (Leu(UUR)) gene in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Biochem Biophys Res Commun 1994;202:1624-30
27. Sato W, Hayasaka K, Shoji Y, et al. A mitochondrial tRNA(leu)(UUR) mutation at 3256 associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochem Mol Biol Int 1994;33:1055-61
28. Bataillard M, Chatzoglou E, Rumbach L, et al. Atypical MELAS syndrome associated with a new mitochondrial tRNA glutamine point mutation. Neurology 2001;56:405-7
29. King MP, Koga Y, Davidson M, et al. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes. Mol Cell Biol 1992;12:480-90
30. Yamamoto M, Sato T, Anno M, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes with recurrent abdominal symptoms and coenzyme Q10 administration. J Neurol Neurosurg Psychiatry 1987;50:1475-81
31. Penn AMW, Lee JWK, Thuillier P, et al. MELAS syndrome with mitochondrial tRNALeu (UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin. Neurology 1992;42:2147-52
32. Koga Y, Akita Y, Nishioka J, et al. L-Arginine improves the symptoms of strokelike episodes in MELAS. Neurology 2005;64:710-12
33. Chinnery PF, Majamaa K, Turnbull D, et al. Treatment for mitochondrial disorders. Cochrane Database Syst Rev 2006;(1):CD004426.
34. Bresolin N, Doriguzzi C, Ponzetto C, et al. Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial. J Neurol Sci 1990;100:70-8
35. Ikejiri Y, Mori E, Ishii K, et al. Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS. Neurology 1996;47:583-5
36. Koga Y, Akita J, Nishioka S, et al. MELAS and L-arginine therapy. Mitochondrion 2007;7:133-9
37. Koga Y, Ishibashi M, Ueki I, et al. Effects of L-arginine on the acute phase of strokes in three patients with MELAS. Neurology 2002;58:827-8
38. Penn AMW, Lee JWK, Thuillier P, et al. MELAS syndrome with mitochondrial tRNALeu (UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin. Neurology 1992;42:2147-52
39. Kaufmann P, Engelstad Y, Wei Y, et al. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology 2006;66:324-30
40. Taivassalo T, Fu K, Johns T, et al. Gene shifting: a novel therapy for mitochondrial myopathy. Hum Mol Genet 1999;8:1047-52
41. Santra S, Gilkerson RW, Davidson M, et al. Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells. Ann Neurol 2004;56:662-9
42. Ahola-Erkkila S, Carrol CJ, Peltola-Mjösund K, et al. Ketogenic diet slows down mitochondrial myopathy progression in mice. Hum Mol Genet 2010;19:1974-84
43. Wai T, Teoli D, Shoubridge EA. The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes. Nat Genet 2008;40:1484-8
44. Craven L, Tuppen HA, Greggains GD, et al. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 2010;465:82-5